OpenAI Unveils GPT-Rosalind for Life Sciences

OpenAI launched GPT-Rosalind, its first AI model tailored for biochemistry and genomics ^[1][2]. The model helps researchers synthesize data and design biological experiments ^[1]. It is named after chemist Rosalind Franklin, whose work was vital to understanding DNA structure ^[2]. The tool is currently in limited release with partners like Amgen and Moderna ^[2]. OpenAI designed the reasoning model to compete with systems like Google’s AlphaFold ^[3]. GPT-Rosalind can generate new biological hypotheses and assist in protein engineering ^[1][2]. OpenAI also debuted a related Codex plugin on GitHub to support broader development ^[1]. This launch marks a shift toward specialized AI tools for the life sciences industry ^[1][3].